Free
energy
perturbation
(FEP)
remains
an
indispensable
method
for
computationally
assaying
prospective
compounds
in
advance
of
synthesis.
But
before
FEP
can
be
deployed
prospectively,
it
must
demonstrate
retrospective
recapitulation
known
experimental
data
where
the
subtle
details
atomic
ligand-receptor
model
are
consequential.
An
open
question
is
whether
AlphaFold
models
serve
as
useful
initial
regime
there
exists
a
congeneric
series
chemical
matter
but
no
structures
available
either
target
or
close
homologues.
As
provided
without
ligand
bound,
we
employ
induced-fit
docking
to
refine
presence
one
more
ligands.
In
this
work,
first
validate
performance
our
latest
technology,
IFD-MD
on
set
public
GPCR
with
95%
crossdocks
produc-ing
pose
RMSD
≤
2.5
Å
top
2
predictions.
We
then
apply
and
somatostatin
receptor
family
GPCRs.
use
produced
prior
availability
any
experi-mental
structure
from
within
family.
arrive
at
FEP-validated
SSTR2,
SSTR4,
SSTR5,
RMSE
around
1
kcal/mol
explore
challenges
validation
under
scenarios
limited
ligand-data,
ample
data,
categorical
data.
iScience,
Год журнала:
2022,
Номер
26(1), С. 105920 - 105920
Опубликована: Дек. 30, 2022
A
crucial
component
in
structure-based
drug
discovery
is
the
availability
of
high-quality
three-dimensional
structures
protein
target.
Whenever
experimental
were
not
available,
homology
modeling
has
been,
so
far,
method
choice.
Recently,
AlphaFold
(AF),
an
artificial-intelligence-based
structure
prediction
method,
shown
impressive
results
terms
model
accuracy.
This
outstanding
success
prompted
us
to
evaluate
how
accurate
AF
models
are
from
perspective
docking-based
discovery.
We
compared
high-throughput
docking
(HTD)
performance
with
their
corresponding
PDB
using
a
benchmark
set
22
targets.
The
showed
consistently
worse
four
programs
and
two
consensus
techniques.
Although
shows
remarkable
ability
predict
architecture,
this
might
be
enough
guarantee
that
can
reliably
used
for
HTD,
post-modeling
refinement
strategies
key
increase
chances
success.
Journal of Chemical Information and Modeling,
Год журнала:
2023,
Номер
63(6), С. 1668 - 1674
Опубликована: Март 9, 2023
Machine
learning-based
protein
structure
prediction
algorithms,
such
as
RosettaFold
and
AlphaFold2,
have
greatly
impacted
the
structural
biology
field,
arousing
a
fair
amount
of
discussion
around
their
potential
role
in
drug
discovery.
While
there
are
few
preliminary
studies
addressing
usage
these
models
virtual
screening,
none
them
focus
on
prospect
hit-finding
real-world
screen
with
model
based
low
prior
information.
In
order
to
address
this,
we
developed
an
AlphaFold2
version
where
exclude
all
templates
more
than
30%
sequence
identity
from
model-building
process.
previous
study,
used
those
conjunction
state-of-the-art
free
energy
perturbation
methods
demonstrated
that
it
is
possible
obtain
quantitatively
accurate
results.
this
work,
using
structures
rigid
receptor-ligand
docking
studies.
Our
results
indicate
out-of-the-box
Alphafold2
not
ideal
scenario
for
screening
campaigns;
fact,
strongly
recommend
include
some
post-processing
modeling
drive
binding
site
into
realistic
holo
model.
AlphaFold2
(AF2)
models
have
had
wide
impact
but
mixed
success
in
retrospective
ligand
recognition.
We
prospectively
docked
large
libraries
against
unrefined
AF2
of
the
σ
ACS Medicinal Chemistry Letters,
Год журнала:
2023,
Номер
14(3), С. 244 - 250
Опубликована: Фев. 16, 2023
Rigorous
physics-based
methods
to
calculate
binding
free
energies
of
protein–ligand
complexes
have
become
a
valued
component
structure-based
drug
design.
Relative
and
absolute
energy
calculations
been
deployed
prospectively
in
support
solving
diverse
discovery
challenges.
Here
we
review
recent
applications
fragment
growing
linking,
scaffold
hopping,
pose
validation,
virtual
screening,
covalent
enzyme
inhibition,
positional
analogue
scanning.
Furthermore,
discuss
the
merits
using
protein
models
highlight
efforts
replace
costly
with
predictions
from
machine
learning
trained
on
limited
number
perturbation
or
thermodynamic
integration
thereby
allowing
for
extended
chemical
space
exploration.
Molecular
dynamics
(MD)
simulations
and
computer-aided
drug
design
(CADD)
have
advanced
substantially
over
the
past
two
decades,
thanks
to
continuous
computer
hardware
software
improvements.
Given
these
advancements,
MD
are
poised
become
even
more
powerful
tools
for
investigating
dynamic
interactions
between
potential
small-molecule
drugs
their
target
proteins,
with
significant
implications
pharmacological
research.
Journal of Chemical Information and Modeling,
Год журнала:
2024,
Номер
64(19), С. 7214 - 7237
Опубликована: Окт. 3, 2024
Computational
methods
constitute
efficient
strategies
for
screening
and
optimizing
potential
drug
molecules.
A
critical
factor
in
this
process
is
the
binding
affinity
between
candidate
molecules
targets,
quantified
as
free
energy.
Among
various
estimation
methods,
alchemical
transformation
stand
out
their
theoretical
rigor.
Despite
challenges
force
field
accuracy
sampling
efficiency,
advancements
algorithms,
software,
hardware
have
increased
application
of
energy
perturbation
(FEP)
calculations
pharmaceutical
industry.
Here,
we
review
practical
applications
FEP
discovery
projects
since
2018,
covering
both
ligand-centric
residue-centric
transformations.
We
show
that
relative
steadily
achieved
chemical
real-world
applications.
In
addition,
discuss
alternative
physics-based
simulation
incorporation
deep
learning
into
calculations.
Journal of Chemical Theory and Computation,
Год журнала:
2023,
Номер
20(1), С. 477 - 489
Опубликована: Дек. 15, 2023
Free
energy
perturbation
(FEP)
remains
an
indispensable
method
for
computationally
assaying
prospective
compounds
in
advance
of
synthesis.
However,
before
FEP
can
be
deployed
prospectively,
it
must
demonstrate
retrospective
recapitulation
known
experimental
data
where
the
subtle
details
atomic
ligand-receptor
model
are
consequential.
An
open
question
is
whether
AlphaFold
models
serve
as
useful
initial
regime
there
exists
a
congeneric
series
chemical
matter
but
no
structures
available
either
target
or
close
homologues.
As
provided
without
bound
ligand,
we
employ
induced
fit
docking
to
refine
presence
one
more
ligands.
In
this
work,
first
validate
performance
our
latest
technology,
IFD-MD,
on
set
public
GPCR
with
95%
cross-docks
producing
pose
ligand
RMSD
≤
2.5
Å
top
two
predictions.
We
then
apply
IFD-MD
and
somatostatin
receptor
family
GPCRs.
use
produced
prior
availability
any
structure
from
family.
arrive
at
FEP-validated
SSTR2,
SSTR4,
SSTR5,
RMSE
around
1
kcal/mol,
explore
challenges
validation
under
scenarios
limited
data,
ample
categorical
data.
Pharmaceuticals,
Год журнала:
2023,
Номер
16(12), С. 1662 - 1662
Опубликована: Ноя. 29, 2023
With
technology
advancing,
many
prediction
algorithms
have
been
developed
to
facilitate
the
modeling
of
inherently
dynamic
and
flexible
macromolecules
such
as
proteins.
Improvements
in
protein
structures
attracted
a
great
deal
attention
due
advantages
they
offer,
e.g.,
drug
design.
While
trusted
experimental
methods,
X-ray
crystallography,
NMR
spectroscopy,
electron
microscopy,
are
preferred
structure
analysis
techniques,
silico
approaches
also
being
widely
used.
Two
computational
which
on
opposite
ends
spectrum
with
respect
their
modus
operandi,
i.e.,
homology
AlphaFold,
established
provide
high-quality
structures.
Here,
comparative
study
quality
either
predicted
by
or
AlphaFold
is
presented
based
characteristics
determined
studies
using
validation
servers
fulfill
purpose.
Although
able
predict
structures,
high-confidence
parts
sometimes
observed
be
disagreement
data.
On
other
hand,
while
obtained
from
successful
incorporating
all
aspects
used
template,
this
method
may
struggle
accurately
model
absence
suitable
template.
In
general,
although
both
methods
produce
models,
criteria
superior
each
different
thus
discussed
detail.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 21, 2023
AlphaFold2
(AF2)
and
RosettaFold
have
greatly
expanded
the
number
of
structures
available
for
structure-based
ligand
discovery,
even
though
retrospective
studies
cast
doubt
on
their
direct
usefulness
that
goal.
Here,
we
tested
unrefined
AF2
models
prospectively,
comparing
experimental
hit-rates
affinities
from
large
library
docking
against
vs
same
screens
targeting
receptors.
In
σ2
5-HT2A
receptors,
struggled
to
recapitulate
ligands
had
previously
found
receptors'
structures,
consistent
with
published
results.
Prospective
models,
however,
yielded
similar
hit
rates
both
receptors
versus
experimentally-derived
structures;
hundreds
molecules
were
prioritized
each
model
structure
receptor.
The
success
was
achieved
despite
differences
in
orthosteric
pocket
residue
conformations
targets
structures.
Intriguingly,
receptor
most
potent,
subtype-selective
agonists
discovered
via
model,
not
structure.
To
understand
this
a
molecular
perspective,
cryoEM
determined
one
more
potent
selective
emerge
Our
findings
suggest
may
sample
are
relevant
much
extending
domain
applicability
discovery.